MyAverix Finance
SHG · Healthcare
Beijing Winsunny Pharmaceutical CO.LTD (601089)
Drug Manufacturers - Specialty & Generic
Beijing Winsunny Pharmaceutical CO.LTD (601089) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $11.18B, P/E ratio is 24.02, net margin is 13.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 601089
Beijing Winsunny Pharmaceutical CO.LTD (601089) — FAQ
What is Beijing Winsunny Pharmaceutical CO.LTD's market cap?
Beijing Winsunny Pharmaceutical CO.LTD (601089) has a reported market cap of $11.18B (data as of 2026-03-28).
What is 601089's P/E ratio?
The price-to-earnings (P/E) ratio for Beijing Winsunny Pharmaceutical CO.LTD (601089) is 24.02 (data as of 2026-03-28).
Does Beijing Winsunny Pharmaceutical CO.LTD pay a dividend?
Dividend yield is not available in the current snapshot for Beijing Winsunny Pharmaceutical CO.LTD (601089). Check the MyAverix Finance app for the latest dividend data.
What sector is Beijing Winsunny Pharmaceutical CO.LTD in?
Beijing Winsunny Pharmaceutical CO.LTD (601089) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 601089 listed on?
601089 is listed on SHG.
What is Beijing Winsunny Pharmaceutical CO.LTD's net margin?
Beijing Winsunny Pharmaceutical CO.LTD (601089) reports a net margin of 13.5% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.